We’re launching Lyria 3.5 in Google Flow Music, with advances across musicality, lyrics, vocals, and creative control
deepmind.google·6d ago
AI Engineering
DeepMind Blog·Oct 23·5 min read
How a Gemma model helped discover a new potential cancer therapy pathway
TL;DR
Cancer therapies often struggle to effectively engage the immune system against tumors. The C2S-Scale model, developed by Google DeepMind and Yale, identified a drug combination that enhances tumor visibility to immune cells.
✦ Why It Matters
Engineers and researchers can leverage the C2S-Scale model to explore innovative cancer therapies and enhance immune system engagement.
Key Takeaways
- Utilize C2S-Scale for drug discovery in cancer therapy.
- Investigate the role of silmitasertib in enhancing immune response.
- Apply dual-context virtual screening for targeted drug combinations.
- Collaborate with research teams to validate AI-generated hypotheses.
How It Works
C2S-Scale employs a dual-context virtual screening method to identify drug combinations that enhance antigen presentation in specific immune environments. By simulating drug effects in both immune-context-positive and immune-context-neutral settings, the model can predict which drugs will effectively amplify immune signals only when conditions are favorable.